Systemic barriers to timely stroke treatment highlight gaps in global healthcare equity and medical innovation
Original framing: “[Comment] Intravenous tenecteplase for acute ischaemic stroke within 24 h due to basilar artery occlusion” — The Lancet
The framing omits indigenous medical practices, historical parallels in stroke treatment, and the perspectives of patients in low-income countries who lack access to advanced interventions.
Medium structural omission detected in mainstream coverage.
The narrative is produced by Western medical institutions for a global audience, reinforcing the dominance of pharmaceutical solutions over systemic healthcare reform. It obscures the structural barriers in low-resource settings that prevent timely stroke intervention.
The study provides rigorous evidence for tenecteplase but lacks broader systemic analysis of healthcare access disparities.